TG c.1033_1034delinsAG ;(p.E345R)

Variant ID: 8-133895202-GA-AG

NM_003235.4(TG):c.1033_1034delinsAG;(p.E345R)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


A Highly Expressing, Soluble, and Stable Plant-Made IgG Fusion Vaccine Strategy Enhances Antigen Immunogenicity in Mice Without Adjuvant.

Frontiers In Immunology
Diamos, Andrew G AG; Pardhe, Mary D MD; Sun, Haiyan H; Hunter, Joseph G L JGL; Kilbourne, Jacquelyn J; Chen, Qiang Q; Mason, Hugh S HS
Publication Date: 2020

Variant appearance in text: TG: E345R
PubMed Link: 33343565
Variant Present in the following documents:
  • fimmu-11-576012.pdf
View BVdb publication page



Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?

Frontiers In Immunology
Marshall, Michael J E MJE; Stopforth, Richard J RJ; Cragg, Mark S MS
Publication Date: 2017

Variant appearance in text: TG: E345R
PubMed Link: 29046676
Variant Present in the following documents:
  • Main text
  • fimmu-08-01245.pdf
View BVdb publication page